These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 4309463

  • 41. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
    Konaga E.
    Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
    [No Abstract] [Full Text] [Related]

  • 42. [Use of Ehrlich ascites carcinoma in working with para-influenza viruses].
    Zakstel'skaia LIa, Konovalova NG.
    Vopr Virusol; 1968 Aug; 13(3):306-9. PubMed ID: 4302359
    [No Abstract] [Full Text] [Related]

  • 43. Antigenic relationships of various fractions of the Ehrlich ascites tumor investigated by different immunoserological methods.
    Eng CP, Hindmarsh JA, Morgan JF.
    Can J Microbiol; 1969 Sep; 15(9):1085-90. PubMed ID: 4984462
    [No Abstract] [Full Text] [Related]

  • 44. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A, Brambilla P, Mocarelli P.
    Biomedicine; 1980 Sep; 33(4):105-9. PubMed ID: 7000194
    [Abstract] [Full Text] [Related]

  • 45. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ, Prescott DM, Ogilvie GK.
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Observations on H 10 ZE mixed tumor.
    Fadei L.
    Oncology; 1971 Jun; 25(5):385-400. PubMed ID: 4335471
    [No Abstract] [Full Text] [Related]

  • 50. Loss of transplantability and induction of immunoprotection by mouse ascites tumor cells in tissue culture.
    Morgan JF, Eng CP, Heuchert MD, Kirk HD.
    Proc Soc Exp Biol Med; 1970 May; 134(1):305-8. PubMed ID: 5423517
    [No Abstract] [Full Text] [Related]

  • 51. Tumour immunity with treated ascites cells.
    Das A, Roy DK.
    Indian J Exp Biol; 1980 Jun; 18(6):635-6. PubMed ID: 7439947
    [No Abstract] [Full Text] [Related]

  • 52. Immune reactions in Ehrlich ascites tumour-bearing mice.
    Olinescu A, Babeş S, Piţur I.
    Arch Roum Pathol Exp Microbiol; 1980 Jun; 39(3):249-57. PubMed ID: 7018456
    [No Abstract] [Full Text] [Related]

  • 53. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T, Henderson S, van der Noen HM.
    Tumour Biol; 2000 Jun; 21(3):145-52. PubMed ID: 10754465
    [Abstract] [Full Text] [Related]

  • 54. [Effect of the immunologic status of the host on the percentage of polyploid cells in Ehrlich's ascites tumor].
    Dux K, Czarnomska A, Bregula U.
    Nowotwory; 1973 Jun; 23(1):7-13. PubMed ID: 4715450
    [No Abstract] [Full Text] [Related]

  • 55. Effect of purine-protein conjugates on the Ehrlich ascites tumor in mice.
    Lachman C, Cohen S.
    Cancer Res; 1970 Feb; 30(2):439-46. PubMed ID: 5441091
    [No Abstract] [Full Text] [Related]

  • 56. Progressive karyotypic changes in vitro in the Ehrlich Lettré ascites subline SZEL.
    Stephenson EM, Stephenson NG.
    Eur J Cancer (1965); 1973 Apr; 9(4):273-9. PubMed ID: 4778370
    [No Abstract] [Full Text] [Related]

  • 57. [Somatic hybridization and cell malignancy].
    Barski G.
    Bull Cancer; 1970 Apr; 57(2):185-94. PubMed ID: 5493522
    [No Abstract] [Full Text] [Related]

  • 58. Demonstration of immune adherence-blocking factors in cell-free tumorous ascites.
    Kaneko Y, Nitta K.
    Gan; 1974 Jun; 65(3):201-5. PubMed ID: 4851294
    [No Abstract] [Full Text] [Related]

  • 59. Procedure for the large-scale production of mouse interferons with Ehrlich ascites tumor cells.
    Broeze R, Jayaram B, Slattery E, Taira H, Lengyel P.
    Methods Enzymol; 1981 Jun; 78(Pt A):143-7. PubMed ID: 6173580
    [No Abstract] [Full Text] [Related]

  • 60. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S, Mondal S.
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.